Metabolomics analysis elucidates unique influences on purine / pyrimidine metabolism by xanthine oxidoreductase inhibitors in a rat model of renal ischemia-reperfusion injury
Abstract Background Clinically applied as anti-gout drugs, xanthine oxidoreductase (XOR) inhibitors, especially the potent, selective, non-purine-analog XOR inhibitors febuxostat and topiroxostat, exert organ-protective effects. We tested the hypothesis that preservation of tissue concentrations of...
Saved in:
Main Authors: | Takashi Tani (Author), Ken Okamoto (Author), Megumi Fujiwara (Author), Akira Katayama (Author), Shuichi Tsuruoka (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pro-Aging Effects of Xanthine Oxidoreductase Products
by: Maria Giulia Battelli, et al.
Published: (2020) -
Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease
by: Hunter W. Korsmo, et al.
Published: (2024) -
Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia
by: Marta Romo-González, et al.
Published: (2020) -
Metabolomics-Driven Elucidation of Cellular Nitrate Tolerance Reveals Ascorbic Acid Prevents Nitroglycerin-Induced Inactivation of Xanthine Oxidase
by: Elizabeth Rose Axton, et al.
Published: (2018) -
Plasma Xanthine Oxidoreductase Activity Associated with Glycemic Control in Patients with Pre-Dialysis Chronic Kidney Disease
by: Shinya Nakatani, et al.
Published: (2021)